APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cardiac Troponin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cardiac Troponin Industry Growth and Trends Forecast to 2032

Report ID 173975100120 December 2025107 pages

Choose your research edition.

Industry ResearchCardiac Troponin Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac Troponin Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Cardiac Troponin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac Troponin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac Troponin Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cardiac Troponin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cardiac Troponin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cardiac Troponin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiac Troponin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cardiac Troponin include Roche, Singulex, Siemens Healthcare Diagnostics, Ortho Clinical Diagnostics, LifeSign, bioMrieux, BG Medicine, Beckman Coulter and Alere, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cardiac Troponin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cardiac Troponin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cardiac Troponin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cardiac Troponin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cardiac Troponin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cardiac Troponin Market by Company

Roche

Singulex

Siemens Healthcare Diagnostics

Ortho Clinical Diagnostics

LifeSign

bioMrieux

BG Medicine

Beckman Coulter

Alere

Abbott Diagnostics

Cardiac Troponin Segment by Type

Laboratory Testing

Point-of-care Testing

Cardiac Troponin Segment by Application

Myocardial Infarction

Acute Coronary Syndrome

Congestive Heart Failure

Others

Cardiac Troponin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac Troponin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac Troponin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac Troponin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cardiac Troponin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cardiac Troponin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Laboratory Testing Table 2. Major Company of Point-of-care Testing Table 3. Global Cardiac Troponin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cardiac Troponin Sales by Type (2021-2026) & (K Units) Table 5. Global Cardiac Troponin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cardiac Troponin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cardiac Troponin Sales Market Share in Value by Type (2021-2026) Table 8. Global Cardiac Troponin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Cardiac Troponin Sales by Type (2027-2032) & (K Units) Table 10. Global Cardiac Troponin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cardiac Troponin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cardiac Troponin Sales Market Share in Value by Type (2027-2032) Table 13. Global Cardiac Troponin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Cardiac Troponin Sales by Type (2021-2026) & (K Units) Table 15. North America Cardiac Troponin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cardiac Troponin Sales by Type (2021-2026) & (K Units) Table 17. Europe Cardiac Troponin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cardiac Troponin Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Cardiac Troponin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cardiac Troponin Sales by Type (2021-2026) & (K Units) Table 21. Latin America Cardiac Troponin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cardiac Troponin Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Cardiac Troponin Sales by Type (2021-2026) & (US$ Million) Table 24. Cardiac Troponin Industry Trends Table 25. Cardiac Troponin Industry Drivers Table 26. Cardiac Troponin Industry Opportunities and Challenges Table 27. Cardiac Troponin Industry Restraints Table 28. Global Cardiac Troponin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cardiac Troponin Revenue Market Share by Company (2021-2026) Table 30. Global Cardiac Troponin Sales by Company (2021-2026) & (K Units) Table 31. Global Cardiac Troponin Sales Share by Company (2021-2026) Table 32. Global Cardiac Troponin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Cardiac Troponin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cardiac Troponin Major Company Production Sites and Headquarters Table 35. Global Cardiac Troponin Company, Product Type & Application Table 36. Global Cardiac Troponin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cardiac Troponin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cardiac Troponin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cardiac Troponin Sales by Region (2021-2026) & (K Units) Table 41. Global Cardiac Troponin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cardiac Troponin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cardiac Troponin Sales Market Share in Value by Region (2021-2026) Table 44. Global Cardiac Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Cardiac Troponin Sales by Region (2027-2032) & (K Units) Table 46. Global Cardiac Troponin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cardiac Troponin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cardiac Troponin Sales Market Share in Value by Region (2027-2032) Table 49. Global Cardiac Troponin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Cardiac Troponin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cardiac Troponin Sales by Application (2021-2026) & (K Units) Table 52. Global Cardiac Troponin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cardiac Troponin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cardiac Troponin Sales Market Share in Value by Application (2021-2026) Table 55. Global Cardiac Troponin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Cardiac Troponin Sales by Application (2027-2032) & (K Units) Table 57. Global Cardiac Troponin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cardiac Troponin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cardiac Troponin Sales Market Share in Value by Application (2027-2032) Table 60. Global Cardiac Troponin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Cardiac Troponin Sales by Application (2021-2026) & (K Units) Table 62. North America Cardiac Troponin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cardiac Troponin Sales by Application (2021-2026) & (K Units) Table 64. Europe Cardiac Troponin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cardiac Troponin Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Cardiac Troponin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cardiac Troponin Sales by Application (2021-2026) & (K Units) Table 68. Latin America Cardiac Troponin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cardiac Troponin Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Cardiac Troponin Sales by Application (2021-2026) & (US$ Million) Table 71. Roche Company Information Table 72. Roche Business Overview Table 73. Roche Cardiac Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Roche Cardiac Troponin Product Portfolio Table 75. Roche Recent Development Table 76. Singulex Company Information Table 77. Singulex Business Overview Table 78. Singulex Cardiac Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Singulex Cardiac Troponin Product Portfolio Table 80. Singulex Recent Development Table 81. Siemens Healthcare Diagnostics Company Information Table 82. Siemens Healthcare Diagnostics Business Overview Table 83. Siemens Healthcare Diagnostics Cardiac Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Siemens Healthcare Diagnostics Cardiac Troponin Product Portfolio Table 85. Siemens Healthcare Diagnostics Recent Development Table 86. Ortho Clinical Diagnostics Company Information Table 87. Ortho Clinical Diagnostics Business Overview Table 88. Ortho Clinical Diagnostics Cardiac Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ortho Clinical Diagnostics Cardiac Troponin Product Portfolio Table 90. Ortho Clinical Diagnostics Recent Development Table 91. LifeSign Company Information Table 92. LifeSign Business Overview Table 93. LifeSign Cardiac Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. LifeSign Cardiac Troponin Product Portfolio Table 95. LifeSign Recent Development Table 96. bioMrieux Company Information Table 97. bioMrieux Business Overview Table 98. bioMrieux Cardiac Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. bioMrieux Cardiac Troponin Product Portfolio Table 100. bioMrieux Recent Development Table 101. BG Medicine Company Information Table 102. BG Medicine Business Overview Table 103. BG Medicine Cardiac Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. BG Medicine Cardiac Troponin Product Portfolio Table 105. BG Medicine Recent Development Table 106. Beckman Coulter Company Information Table 107. Beckman Coulter Business Overview Table 108. Beckman Coulter Cardiac Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Beckman Coulter Cardiac Troponin Product Portfolio Table 110. Beckman Coulter Recent Development Table 111. Alere Company Information Table 112. Alere Business Overview Table 113. Alere Cardiac Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Alere Cardiac Troponin Product Portfolio Table 115. Alere Recent Development Table 116. Abbott Diagnostics Company Information Table 117. Abbott Diagnostics Business Overview Table 118. Abbott Diagnostics Cardiac Troponin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Abbott Diagnostics Cardiac Troponin Product Portfolio Table 120. Abbott Diagnostics Recent Development Table 121. North America Cardiac Troponin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Cardiac Troponin Sales by Country (2021-2026) & (K Units) Table 123. North America Cardiac Troponin Sales Market Share by Country (2021-2026) Table 124. North America Cardiac Troponin Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Cardiac Troponin Sales Market Share Forecast by Country (2027-2032) Table 126. North America Cardiac Troponin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Cardiac Troponin Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Cardiac Troponin Market Share by Country (2021-2026) Table 129. North America Cardiac Troponin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Cardiac Troponin Market Share Forecast by Country (2027-2032) Table 131. Europe Cardiac Troponin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Cardiac Troponin Sales by Country (2021-2026) & (K Units) Table 133. Europe Cardiac Troponin Sales Market Share by Country (2021-2026) Table 134. Europe Cardiac Troponin Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Cardiac Troponin Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Cardiac Troponin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Cardiac Troponin Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Cardiac Troponin Market Share by Country (2021-2026) Table 139. Europe Cardiac Troponin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Cardiac Troponin Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Cardiac Troponin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Cardiac Troponin Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Cardiac Troponin Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Cardiac Troponin Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Cardiac Troponin Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Cardiac Troponin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Cardiac Troponin Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Cardiac Troponin Market Share by Country (2021-2026) Table 149. Asia-Pacific Cardiac Troponin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Cardiac Troponin Market Share Forecast by Country (2027-2032) Table 151. Latin America Cardiac Troponin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Cardiac Troponin Sales by Country (2021-2026) & (K Units) Table 153. Latin America Cardiac Troponin Sales Market Share by Country (2021-2026) Table 154. Latin America Cardiac Troponin Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Cardiac Troponin Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Cardiac Troponin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Cardiac Troponin Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Cardiac Troponin Market Share by Country (2021-2026) Table 159. Latin America Cardiac Troponin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Cardiac Troponin Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Cardiac Troponin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Cardiac Troponin Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Cardiac Troponin Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Cardiac Troponin Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Cardiac Troponin Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Cardiac Troponin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Cardiac Troponin Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Cardiac Troponin Market Share by Country (2021-2026) Table 169. Middle East and Africa Cardiac Troponin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Cardiac Troponin Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Cardiac Troponin Distributors List Table 174. Cardiac Troponin Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Cardiac Troponin Image Figure 2. Global Cardiac Troponin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiac Troponin Market Size (2021-2032) & (US$ Million) Figure 4. Global Cardiac Troponin Sales (2021-2032) & (K Units) Figure 5. Laboratory Testing Image Figure 6. Global Laboratory Testing Sales YoY Growth (2021-2032) & (K Units) Figure 7. Point-of-care Testing Image Figure 8. Global Point-of-care Testing Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Cardiac Troponin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cardiac Troponin Market Share by Type 2025 VS 2032 Figure 11. North America Cardiac Troponin Sales Market Share in Volume by Type in 2025 Figure 12. North America Cardiac Troponin Sales Market Share in Value by Type in 2025 Figure 13. Europe Cardiac Troponin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cardiac Troponin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cardiac Troponin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cardiac Troponin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cardiac Troponin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cardiac Troponin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cardiac Troponin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cardiac Troponin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cardiac Troponin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Myocardial Infarction Image Figure 24. Global Myocardial Infarction Sales YoY Growth (2021-2032) & (K Units) Figure 25. Acute Coronary Syndrome Image Figure 26. Global Acute Coronary Syndrome Sales YoY Growth (2021-2032) & (K Units) Figure 27. Congestive Heart Failure Image Figure 28. Global Congestive Heart Failure Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Cardiac Troponin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cardiac Troponin Market Share by Application 2025 VS 2032 Figure 33. North America Cardiac Troponin Sales Market Share in Volume by Application in 2025 Figure 34. North America Cardiac Troponin Sales Market Share in Value by Application in 2025 Figure 35. Europe Cardiac Troponin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cardiac Troponin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cardiac Troponin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cardiac Troponin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cardiac Troponin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cardiac Troponin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cardiac Troponin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cardiac Troponin Sales Market Share in Value by Application in 2025 Figure 43. North America Cardiac Troponin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Cardiac Troponin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cardiac Troponin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cardiac Troponin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cardiac Troponin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Cardiac Troponin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cardiac Troponin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cardiac Troponin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cardiac Troponin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Cardiac Troponin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cardiac Troponin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cardiac Troponin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cardiac Troponin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Cardiac Troponin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cardiac Troponin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cardiac Troponin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cardiac Troponin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Cardiac Troponin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cardiac Troponin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cardiac Troponin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cardiac Troponin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cardiac Troponin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Laboratory Testing
  • Point-of-care Testing
Applications
  • Myocardial Infarction
  • Acute Coronary Syndrome
  • Congestive Heart Failure
  • Others
Companies covered
  • Roche
  • Singulex
  • Siemens Healthcare Diagnostics
  • Ortho Clinical Diagnostics
  • LifeSign
  • bioMrieux
  • BG Medicine
  • Beckman Coulter
  • Alere
  • Abbott Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cardiac Troponin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cardiac Troponin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cardiac Troponin Market by Type
  6. 1.3.1 Laboratory Testing
  7. 1.3.2 Point-of-care Testing
  8. 1.4 Global Cardiac Troponin Market Size by Type
  9. 1.4.1 Global Cardiac Troponin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cardiac Troponin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cardiac Troponin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cardiac Troponin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cardiac Troponin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cardiac Troponin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cardiac Troponin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cardiac Troponin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cardiac Troponin Industry Trends
  2. 2.2 Cardiac Troponin Industry Drivers
  3. 2.3 Cardiac Troponin Industry Opportunities and Challenges
  4. 2.4 Cardiac Troponin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cardiac Troponin Revenue (2021-2026)
  2. 3.2 Global Top Players by Cardiac Troponin Sales (2021-2026)
  3. 3.3 Global Top Players by Cardiac Troponin Price (2021-2026)
  4. 3.4 Global Cardiac Troponin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cardiac Troponin Major Company Production Sites & Headquarters
  6. 3.6 Global Cardiac Troponin Company, Product Type & Application
  7. 3.7 Global Cardiac Troponin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cardiac Troponin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cardiac Troponin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cardiac Troponin Tier 1, Tier 2, and Tier 3
4 Cardiac Troponin Regional Status and Outlook
  1. 4.1 Global Cardiac Troponin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cardiac Troponin Historic Market Size by Region
  3. 4.2.1 Global Cardiac Troponin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cardiac Troponin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cardiac Troponin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cardiac Troponin Forecasted Market Size by Region
  7. 4.3.1 Global Cardiac Troponin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cardiac Troponin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cardiac Troponin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cardiac Troponin by Application
  1. 5.1 Cardiac Troponin Market by Application
  2. 5.1.1 Myocardial Infarction
  3. 5.1.2 Acute Coronary Syndrome
  4. 5.1.3 Congestive Heart Failure
  5. 5.1.4 Others
  6. 5.2 Global Cardiac Troponin Market Size by Application
  7. 5.2.1 Global Cardiac Troponin Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cardiac Troponin Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cardiac Troponin Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cardiac Troponin Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cardiac Troponin Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cardiac Troponin Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cardiac Troponin Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cardiac Troponin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Cardiac Troponin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Roche Cardiac Troponin Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Singulex
  8. 6.2.1 Singulex Company Information
  9. 6.2.2 Singulex Business Overview
  10. 6.2.3 Singulex Cardiac Troponin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Singulex Cardiac Troponin Product Portfolio
  12. 6.2.5 Singulex Recent Developments
  13. 6.3 Siemens Healthcare Diagnostics
  14. 6.3.1 Siemens Healthcare Diagnostics Company Information
  15. 6.3.2 Siemens Healthcare Diagnostics Business Overview
  16. 6.3.3 Siemens Healthcare Diagnostics Cardiac Troponin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Siemens Healthcare Diagnostics Cardiac Troponin Product Portfolio
  18. 6.3.5 Siemens Healthcare Diagnostics Recent Developments
  19. 6.4 Ortho Clinical Diagnostics
  20. 6.4.1 Ortho Clinical Diagnostics Company Information
  21. 6.4.2 Ortho Clinical Diagnostics Business Overview
  22. 6.4.3 Ortho Clinical Diagnostics Cardiac Troponin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ortho Clinical Diagnostics Cardiac Troponin Product Portfolio
  24. 6.4.5 Ortho Clinical Diagnostics Recent Developments
  25. 6.5 LifeSign
  26. 6.5.1 LifeSign Company Information
  27. 6.5.2 LifeSign Business Overview
  28. 6.5.3 LifeSign Cardiac Troponin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 LifeSign Cardiac Troponin Product Portfolio
  30. 6.5.5 LifeSign Recent Developments
  31. 6.6 bioMrieux
  32. 6.6.1 bioMrieux Company Information
  33. 6.6.2 bioMrieux Business Overview
  34. 6.6.3 bioMrieux Cardiac Troponin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 bioMrieux Cardiac Troponin Product Portfolio
  36. 6.6.5 bioMrieux Recent Developments
  37. 6.7 BG Medicine
  38. 6.7.1 BG Medicine Company Information
  39. 6.7.2 BG Medicine Business Overview
  40. 6.7.3 BG Medicine Cardiac Troponin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 BG Medicine Cardiac Troponin Product Portfolio
  42. 6.7.5 BG Medicine Recent Developments
  43. 6.8 Beckman Coulter
  44. 6.8.1 Beckman Coulter Company Information
  45. 6.8.2 Beckman Coulter Business Overview
  46. 6.8.3 Beckman Coulter Cardiac Troponin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Beckman Coulter Cardiac Troponin Product Portfolio
  48. 6.8.5 Beckman Coulter Recent Developments
  49. 6.9 Alere
  50. 6.9.1 Alere Company Information
  51. 6.9.2 Alere Business Overview
  52. 6.9.3 Alere Cardiac Troponin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alere Cardiac Troponin Product Portfolio
  54. 6.9.5 Alere Recent Developments
  55. 6.10 Abbott Diagnostics
  56. 6.10.1 Abbott Diagnostics Company Information
  57. 6.10.2 Abbott Diagnostics Business Overview
  58. 6.10.3 Abbott Diagnostics Cardiac Troponin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Abbott Diagnostics Cardiac Troponin Product Portfolio
  60. 6.10.5 Abbott Diagnostics Recent Developments
7 North America by Country
  1. 7.1 North America Cardiac Troponin Sales by Country
  2. 7.1.1 North America Cardiac Troponin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cardiac Troponin Sales by Country (2021-2026)
  4. 7.1.3 North America Cardiac Troponin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cardiac Troponin Market Size by Country
  6. 7.2.1 North America Cardiac Troponin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cardiac Troponin Market Size by Country (2021-2026)
  8. 7.2.3 North America Cardiac Troponin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cardiac Troponin Sales by Country
  2. 8.1.1 Europe Cardiac Troponin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cardiac Troponin Sales by Country (2021-2026)
  4. 8.1.3 Europe Cardiac Troponin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cardiac Troponin Market Size by Country
  6. 8.2.1 Europe Cardiac Troponin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cardiac Troponin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cardiac Troponin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cardiac Troponin Sales by Country
  2. 9.1.1 Asia-Pacific Cardiac Troponin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cardiac Troponin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cardiac Troponin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cardiac Troponin Market Size by Country
  6. 9.2.1 Asia-Pacific Cardiac Troponin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cardiac Troponin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cardiac Troponin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cardiac Troponin Sales by Country
  2. 10.1.1 South America Cardiac Troponin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cardiac Troponin Sales by Country (2021-2026)
  4. 10.1.3 South America Cardiac Troponin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cardiac Troponin Market Size by Country
  6. 10.2.1 South America Cardiac Troponin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cardiac Troponin Market Size by Country (2021-2026)
  8. 10.2.3 South America Cardiac Troponin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cardiac Troponin Sales by Country
  2. 11.1.1 Middle East and Africa Cardiac Troponin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cardiac Troponin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cardiac Troponin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cardiac Troponin Market Size by Country
  6. 11.2.1 Middle East and Africa Cardiac Troponin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cardiac Troponin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cardiac Troponin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cardiac Troponin Value Chain Analysis
  2. 12.1.1 Cardiac Troponin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cardiac Troponin Production Mode & Process
  7. 12.2 Cardiac Troponin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cardiac Troponin Distributors
  10. 12.2.3 Cardiac Troponin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst